Wanwimolruk Sompon, Prachayasittikul Virapong
Center for Innovation Development and Technology Transfer, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand.
Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand.
EXCLI J. 2014 Apr 2;13:347-91. eCollection 2014.
It is well recognized that herbal supplements or herbal medicines are now commonly used. As many patients taking prescription medications are concomitantly using herbal supplements, there is considerable risk for adverse herbal drug interactions. Such interactions can enhance the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index such as warfarin, cyclosporine A and digoxin. Herbal drug interactions can alter pharmacokinetic or/and pharmacodynamic properties of administered drugs. The most common pharmacokinetic interactions usually involve either the inhibition or induction of the metabolism of drugs catalyzed by the important enzymes, cytochrome P450 (CYP). The aim of the present article is to provide an updated review of clinically relevant metabolic CYP-mediated drug interactions between selected herbal supplements and prescription drugs. The commonly used herbal supplements selected include Echinacea, Ginkgo biloba, garlic, St. John's wort, goldenseal, and milk thistle. To date, several significant herbal drug interactions have their origins in the alteration of CYP enzyme activity by various phytochemicals. Numerous herbal drug interactions have been reported. Although the significance of many interactions is uncertain but several interactions, especially those with St. John's wort, may have critical clinical consequences. St. John's wort is a source of hyperforin, an active ingredient that has a strong affinity for the pregnane xenobiotic receptor (PXR). As a PXR ligand, hyperforin promotes expression of CYP3A4 enzymes in the small intestine and liver. This in turn causes induction of CYP3A4 and can reduce the oral bioavailability of many drugs making them less effective. The available evidence indicates that, at commonly recommended doses, other selected herbs including Echinacea, Ginkgo biloba, garlic, goldenseal and milk thistle do not act as potent or moderate inhibitors or inducers of CYP enzymes. A good knowledge of the mechanisms of herbal drug interactions is necessary for assessing and minimizing clinical risks. These processes help prediction of interactions between herbal supplements and prescription drugs. Healthcare professionals should remain vigilant for potential interactions between herbal supplements/medicines and prescription drugs, especially for drugs with a narrow therapeutic index are used.
人们普遍认识到,草药补充剂或草药制剂如今被广泛使用。由于许多服用处方药的患者同时也在使用草药补充剂,因此存在相当大的草药药物不良相互作用风险。此类相互作用会增加个体患者的风险,尤其是对于治疗指数较窄的药物,如华法林、环孢素A和地高辛。草药药物相互作用可改变所给药药物的药代动力学或/和药效学特性。最常见的药代动力学相互作用通常涉及对由重要酶细胞色素P450(CYP)催化的药物代谢的抑制或诱导。本文的目的是对选定的草药补充剂与处方药之间临床上相关的CYP介导的代谢性药物相互作用进行最新综述。选定的常用草药补充剂包括紫锥菊、银杏、大蒜、圣约翰草、白毛茛和水飞蓟。迄今为止,一些重要的草药药物相互作用源于各种植物化学物质对CYP酶活性的改变。已经报道了许多草药药物相互作用。尽管许多相互作用的重要性尚不确定,但一些相互作用,尤其是与圣约翰草的相互作用,可能会产生严重的临床后果。圣约翰草是金丝桃素的来源,金丝桃素是一种对孕烷异生物质受体(PXR)具有强烈亲和力的活性成分。作为一种PXR配体,金丝桃素可促进小肠和肝脏中CYP3A4酶的表达。这反过来会导致CYP3A4的诱导,并可降低许多药物的口服生物利用度,使其效果降低。现有证据表明,在通常推荐的剂量下,其他选定的草药,包括紫锥菊、银杏、大蒜、白毛茛和水飞蓟,不会作为CYP酶的强效或中度抑制剂或诱导剂。了解草药药物相互作用的机制对于评估和最小化临床风险是必要的。这些过程有助于预测草药补充剂与处方药之间的相互作用。医疗保健专业人员应警惕草药补充剂/药物与处方药之间的潜在相互作用,尤其是在使用治疗指数较窄的药物时。